Jump Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jump Financial’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,930	Closed	-$240K	–	2388
2023 Q3	$240K	Sell	12,930 -39,406	-75%	-$446K	0.01%	1420
2023 Q2	$579K	Buy	+52,336	New	+$729K	0.02%	958
2022 Q3	–	Sell	-18,700	Closed	-$258K	–	2095
2022 Q2	$258K	Sell	18,700 -10,661	-36%	-$171K	0.01%	1146
2022 Q1	$478K	Buy	+29,361	New	+$460K	0.02%	835
2021 Q1	–	Sell	-9,883	Closed	-$244K	–	1382
2020 Q4	$244K	Buy	+9,883	New	+$328K	0.04%	688

Jump Financial's ICPT Position: Q4 2023 in Review

Jump Financial sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 12,930 shares — an estimated $240K sold.

Jump Financial first reported a position in ICPT in Q4 2020 and held it in 5 quarters. The position peaked at $579K in Q2 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Jump Financial reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Jump Financial sold 12,930 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $240K.
Jump Financial first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2020 and held it in 5 quarters.
Jump Financial's Intercept Pharmaceuticals, Inc. position peaked at $579K in Q2 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Jump Financial's 13F filing for Q4 2023, filed 7 Feb 2024.